Kaplan–Meier and log-rank tests showed that the 5-year survival rates of patients with high NUSAP1 expression, FIGO III-IV, and residual tumor size > 1 cm were significantly decreased (Fig. 4b). This evidence concerns the gene NUSAP1 and neoplasm.